Treating liver fibrosis and metabolic dysfunction-associated steatohepatitis: Research identifies novel mechanism
The proposed mannequin for FGF21-activated PPP6C in treating liver Fibrosis and metabolic dysfunction-associated steatohepatitis. Credit score: Prof. Li Yu's group...